Technology | Interventional Radiology | June 29, 2018

Embolx Announces FDA Clearance of Next-generation Sniper Balloon Occlusion Microcatheter

Next-generation balloon microcatheter now comes in multiple lengths enabling radial arterial access and improves navigation through complex vascular structures

Embolx Announces FDA Clearance of Next-generation Sniper Balloon Occlusion Microcatheter

June 29, 2018 — Embolx Inc. has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its next-generation family of Sniper Balloon Occlusion Microcatheters for pressure-directed arterial embolization therapy. Now commercially available in the United States, the next-generation family of Sniper devices offers physicians enhanced performance features to improve access and allow easy navigation through small complex vascular structures.

Embolx’s next-generation Sniper microcatheter is now available in three lengths – 110, 130 and 150 cm – now enabling interventional radiologist physicians to access either femoral or radial arterial sites. Advancements in the Sniper’s balloon and atraumatic tip designs allow larger vessels to be occluded and enhance the ability for Sniper to track inside vessels.

The Sniper microcatheter alters blood flow‐dynamics by controlling pressure to increase therapeutic agent delivery into target areas. It is currently used for the treatment of cancerous tumors in the liver and other organs, enlarged prostate (also called benign prostatic hyperplasia) and uterine fibroids. This therapy allows the delivery of drugs and embolic agents to only targeted treatment areas, while protecting surrounding healthy tissues.

"The great thing about Sniper's enhanced design and longer lengths is that it allows me to perform procedures using a transradial approach with the benefits of pressure-directed embolization. The ability to reverse blood flow using Sniper's balloon helps me to not have to worry about non-target embolization," said Aaron M. Fischman, M.D., interventional radiologist and associate professor of radiology and surgery at the Icahn School of Medicine at Mount Sinai. "I can perform the procedure the way I want because of Sniper's wide range compatibility with different guidewires, guide catheters, coils and therapeutic agents."

Embolization is a minimally invasive procedure performed by interventional radiologists where blood supply to organs or tumors are blocked after therapeutic agents are injected in a blood vessel near the treatment location.

For more information: www.embolx.com

Related Content

Henry Ford Hospital's ViewRay MRIdian linear accelerator system allows real-time MRI-guided radiotherapy. Shown is the support staff for this system. In the center of the photo is Benjamin Movsas, M.D., chair of radiation oncology at Henry Ford Cancer Institute. Second from the right is Carrie Glide-Hurst, Ph.D., director of translational research, radiation oncology.

Henry Ford Hospital's ViewRay MRIdian linear accelerator system allows real-time MRI-guided radiotherapy. Shown is the support staff for this system. In the center of the photo is Benjamin Movsas, M.D., chair of radiation oncology at Henry Ford Cancer Institute. Second from the right is Carri Glide-Hurst, Ph.D., director of translational research, radiation oncology.

Feature | Henry Ford Hospital | May 21, 2019 | Dave Fornell, Editor
Henry Ford Hospital thought leaders regularly speak at the radiation oncology and radiology conferences about new res
Philips Launches IntraSight Interventional Applications Platform
Technology | Interventional Radiology | May 20, 2019
Philips announced the launch of the new IntraSight interventional applications platform. The secure, application-based...
Netherlands Hospital to Install State-of-the-Art MRI Ablation Center
News | Magnetic Resonance Imaging (MRI) | May 13, 2019
Imricor announced the signing of a commercial agreement with the Haga Hospital in The Hague, Netherlands to outfit a...
Clinical Trial Explores Opening Blood-Brain Barrier in Fight Against Alzheimer's

Vibhor Krishna, M.D., (right) fits David Shorr with a helmet-like device used in a new clinical trial for Alzheimer’s disease at The Ohio State University Wexner Medical Center. The device uses MRI-guided imaging to deliver focused ultrasound to specific areas of the brain to open the blood-brain barrier. Image courtesy of Ohio State University Wexner Medical Center.

News | Focused Ultrasound Therapy | May 09, 2019
May 9, 2019 — A new clinical trial at The Ohio State University Wexner Medical Center and two other sites is testing
Ultrasonic Device Safe and Effective for Lung Vessel Sealing in Minimally Invasive Lobectomy
News | Interventional Radiology | May 06, 2019
According to a new study, an ultrasonic vessel-sealing device can improve patient outcomes by reducing the incidence of...
360 degree view inside an Interventional radiology lab at Henry Ford Hospital used for neuro-interventions and stroke.
360 Photos | 360 View Photos | May 06, 2019
This is a 360 degree photo view inside the neuro-interventional radiology lab at ...
Multisociety Position Statement Endorses Prostatic Artery Embolization
News | Interventional Radiology | May 02, 2019
A new position statement from interventional radiology professional societies in the U.S. and Europe states that...
Mentice and RAD-AID Collaborate to Improve Access to Interventional Radiology in Resource-constrained Regions
News | Interventional Radiology | April 22, 2019
April 22, 2019 — Mentice AB, provider of endovascular performance solutions, has signed an agreement with the nonprof
Ethicon Launches Global Liver Lesion Ablation Registry
News | Interventional Radiology | April 10, 2019
Johnson & Johnson Medical Devices Companies announced Ethicon has launched a new global registry to collect and...